World's Best Scientists 2026 revealed!
Peter R. Durie

Peter R. Durie

D-Index & Metrics

Medicine

D-Index
88
Citations
28399
World Ranking
13161
National Ranking
541

Overview

Peter R. Durie was affiliated with the University of Toronto in Canada and contributed significantly to research in the field of Medicine, with a particular focus on Pulmonary and Respiratory Medicine, Genetics, Hepatology, Epidemiology, and Emergency Medical Services. Their research work primarily centered around cystic fibrosis and related complications.

Their recent publications included investigations into cystic fibrosis treatment and associated conditions. Notable papers authored or co-authored by them were:

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation, 2020, UNC Libraries
  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation, 2020, UNC Libraries
  • Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis, 2020, UNC Libraries
  • Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis, 2020, UNC Libraries
  • Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis, 2024, Hepatology

Peter R. Durie's research topics spanned multiple areas relevant to cystic fibrosis and liver disease, including:

  • Cystic Fibrosis Research Advances
  • Respiratory Support and Mechanisms
  • Genetic and Kidney Cyst Diseases
  • Digestive system and related health
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology

Their work was frequently published in venues such as:

  • UNC Libraries
  • Hepatology

Throughout their career, Peter R. Durie collaborated extensively with several researchers, including:

  • Rhonda G. Pace
  • Garry R. Cutting
  • Michael R. Knowles
  • Scott M. Blackman
  • Jaclyn R. Stonebraker

Best Publications

  • Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

    Philip M. Farrell;Beryl J. Rosenstein;Terry B. White;Frank J. Accurso

  • Mutations in SBDS are associated with Shwachman–Diamond syndrome

    Graeme R.B. Boocock;Jodi A. Morrison;Maja Popovic;Nicole Richards

  • The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

    Eitan Kerem;Mary Corey;Bat-sheva Kerem;Johanna Rommens

  • Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation

    Frank J. Accurso;Steven M. Rowe;J. P. Clancy;Michael P. Boyle

  • Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

    C. Castellani;H. Cuppens;M. Macek;J. J. Cassiman

  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

    J. P. Clancy;Steven M. Rowe;Frank J. Accurso;Moira L. Aitken

  • Genetic determination of exocrine pancreatic function in cystic fibrosis.

    P. Kristidis;D. Bozon;M. Corey;D. Markiewicz

  • Genetic Modifiers of Lung Disease in Cystic Fibrosis

    Mitchell L. Drumm;Michael W. Konstan;Mark D. Schluchter;Allison Handler

  • Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

    Richard Rozmahel;Michael Wilschanski;Angabin Matin;Suzanne Plyte

  • Definitions of Pediatric Pancreatitis and Survey of Present Clinical Practices

    Veronique D. Morinville;Sohail Z. Husain;Harrison Bai;Bradley Barth

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • High-Dose Pancreatic-Enzyme Supplements and Fibrosing Colonopathy in Children with Cystic Fibrosis

    Stacey C. FitzSimmons;Greg A. Burkhart;Drucy Borowitz;Richard J. Grand

  • Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption

    Kevin Gaskin;Denis Gurwitz;Peter Durie;Mary Corey

  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Sun Gou Ji;Brian D. Juran;Sören Mucha;Trine Folseraas

  • Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy

    Drucy S. Borowitz;Richard J. Grand;Peter R. Durie

  • Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas

    Hinda Kopelman;Mary Corey;Kevin Gaskin;Peter Durie

  • Genetic modifiers of liver disease in cystic fibrosis.

    Jaclyn R. Bartlett;Kenneth J. Friedman;Simon C. Ling;Rhonda G. Pace

  • Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations

    Michael Wilschanski;Julian Zielenski;Danuta Markiewicz;Lap-Chee Tsui

  • Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar.

    Hedy Ginzberg;Janey Shin;Lynda Ellis;Jodi Morrison

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Mary Corey
Mary Corey University of Toronto
Julian Zielenski
Julian Zielenski University of Toronto
Johanna M. Rommens
Johanna M. Rommens University of Toronto
Lap-Chee Tsui
Lap-Chee Tsui University of Toronto
Michael R. Knowles
Michael R. Knowles University of North Carolina at Chapel Hill
Paul B. Pencharz
Paul B. Pencharz University of Toronto
Henry Levison
Henry Levison University of Toronto
Garry R. Cutting
Garry R. Cutting Johns Hopkins University School of Medicine
Fred A. Wright
Fred A. Wright North Carolina State University
Andrew J. Sandford
Andrew J. Sandford University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare careers can open up flexible and affordable options for aspiring professionals. For those interested in administrative roles, the average cost of medical billing and coding program is often significantly less expensive than traditional medical school, making it a practical entry point into the healthcare field.

If your goal is to become a clinical practitioner, there are several nursing pathways to consider. Pursuing a registered nursing degree from affordable nursing programs can be a smart investment, offering quality education without excessive debt. For advanced practice, exploring the cheapest np school options can help you become a nurse practitioner at a lower cost.

Those interested in research or academic leadership can take the next step with phd nursing programs. These online programs provide flexibility for working professionals and help make doctoral-level education more accessible. Overall, online degrees make healthcare careers more achievable, with diverse pathways to suit different goals and budgets.

Best Scientists Citing Peter R. Durie